Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, IWM, UTHR, XBI, BMY, and represent 32.54% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$149M), XBI (+$134M), AZN (+$90M), QQQ (+$87M), IBB (+$80M), RARE (+$72M), AXSM (+$68M), UTHR (+$49M), BIIB (+$42M), CELC (+$42M).
- Started 25 new stock positions in EXEL, IWM, ZYME, XBI, AZN, LQDA, AXGN, OKUR, DFTX, TENX.
- Reduced shares in these 10 stocks: AstraZeneca (-$150M), , , , JAZZ (-$68M), LLY (-$66M), Avidity Biosciences Ord (-$54M), APGE (-$40M), CDTX (-$40M), GKOS (-$33M).
- Sold out of its positions in ABBV, AMLX, APGE, AstraZeneca, Avidity Biosciences Ord, CNTA, CDTX, EVMN, EXACT Sciences Corporation, GEHC. GKOS, ISRG, LLY, MASI, VRTX, QURE.
- Sofinnova Investments was a net buyer of stock by $319M.
- Sofinnova Investments has $2.6B in assets under management (AUM), dropping by 13.45%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Natera (NTRA) | 11.8 | $310M | 1.6M | 199.99 |
|
|
| iShares TR Russell 2000 Etf Put Option (IWM) | 5.7 | $149M | NEW | 600k | 248.00 |
|
| United Therapeutics Corporation Put Option (UTHR) | 5.4 | $143M | +52% | 240k | 592.98 |
|
| SPDR Series Trust State Street Spd Put Option (XBI) | 5.1 | $134M | NEW | 1.1M | 127.73 |
|
| Bristol Myers Squibb (BMY) | 4.6 | $121M | +31% | 2.0M | 60.65 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.3 | $113M | -37% | 598k | 189.05 |
|
| Vera Therapeutics Cl A (VERA) | 4.3 | $112M | 2.8M | 40.23 |
|
|
| AstraZeneca Ord (AZN) | 3.4 | $90M | NEW | 456k | 197.22 |
|
| Invesco QQQ TR Unit Ser 1 Put Option (QQQ) | 3.3 | $87M | NEW | 150k | 577.18 |
|
| Cogent Biosciences (COGT) | 3.1 | $81M | +7% | 2.1M | 38.49 |
|
| iShares TR Ishares Biotech Put Option (IBB) | 3.0 | $80M | NEW | 475k | 168.85 |
|
| Celcuity (CELC) | 2.9 | $76M | +122% | 666k | 114.14 |
|
| Ultragenyx Pharmaceutical (RARE) | 2.8 | $73M | +4096% | 3.5M | 20.95 |
|
| Axsome Therapeutics Put Option (AXSM) | 2.7 | $70M | +3264% | 413k | 169.02 |
|
| Rapport Therapeutics (RAPP) | 2.3 | $60M | 1.9M | 31.29 |
|
|
| Insmed Com Par $.01 (INSM) | 2.2 | $57M | +120% | 346k | 163.52 |
|
| Alcon Ord Shs (ALC) | 2.1 | $55M | +119% | 730k | 75.35 |
|
| Supernus Pharmaceuticals (SUPN) | 1.9 | $49M | +72% | 954k | 51.69 |
|
| BioMarin Pharmaceutical (BMRN) | 1.7 | $44M | +12% | 782k | 56.49 |
|
| Biogen Idec (BIIB) | 1.6 | $42M | NEW | 230k | 183.33 |
|
| Bioage Labs (BIOA) | 1.5 | $40M | 2.3M | 17.49 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 1.5 | $39M | +65% | 450k | 86.97 |
|
| Arrivent Biopharma (AVBP) | 1.5 | $39M | 1.7M | 23.07 |
|
|
| Ideaya Biosciences (IDYA) | 1.4 | $38M | +27% | 1.1M | 33.32 |
|
| Immunome (IMNM) | 1.4 | $37M | +5% | 1.7M | 21.87 |
|
| Nektar Therapeutics (NKTR) | 1.4 | $37M | +16% | 510k | 71.95 |
|
| Immatics SHS (IMTX) | 1.4 | $36M | +5% | 3.6M | 9.84 |
|
| Bridgebio Pharma (BBIO) | 1.2 | $30M | -43% | 409k | 74.26 |
|
| Dyne Therapeutics (DYN) | 1.1 | $30M | -27% | 1.6M | 18.13 |
|
| Inhibrx Biosciences (INBX) | 1.0 | $27M | -10% | 406k | 67.23 |
|
| Dex (DXCM) | 0.9 | $25M | +4% | 394k | 62.80 |
|
| Pharvaris N V (PHVS) | 0.9 | $23M | +9% | 818k | 28.25 |
|
| Pfizer Call Option (PFE) | 0.9 | $23M | NEW | 800k | 28.08 |
|
| Praxis Precision Medicines I (PRAX) | 0.8 | $21M | -49% | 64k | 322.19 |
|
| Genmab A/S Sponsored Ads (GMAB) | 0.8 | $20M | NEW | 752k | 26.83 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.8 | $20M | -15% | 923k | 21.60 |
|
| Liquidia Technologies Put Option (LQDA) | 0.7 | $19M | NEW | 500k | 37.74 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $18M | +409% | 305k | 58.15 |
|
| Stryker Corporation (SYK) | 0.6 | $15M | NEW | 45k | 328.59 |
|
| Anaptysbio Inc Common (ANAB) | 0.5 | $14M | -13% | 248k | 55.46 |
|
| Compass Therapeutics (CMPX) | 0.5 | $14M | -24% | 2.6M | 5.29 |
|
| Roivant Sciences SHS (ROIV) | 0.5 | $13M | -34% | 478k | 27.70 |
|
| Edgewise Therapeutics (EWTX) | 0.5 | $12M | -11% | 387k | 31.50 |
|
| Exelixis Put Option (EXEL) | 0.4 | $11M | NEW | 252k | 42.89 |
|
| Oric Pharmaceuticals (ORIC) | 0.3 | $8.6M | NEW | 680k | 12.67 |
|
| Tango Therapeutics (TNGX) | 0.3 | $8.3M | NEW | 395k | 20.92 |
|
| Tyra Biosciences (TYRA) | 0.3 | $7.8M | NEW | 204k | 38.30 |
|
| Replimune Group Call Option (REPL) | 0.3 | $7.8M | NEW | 1.0M | 7.65 |
|
| Axogen (AXGN) | 0.3 | $7.0M | NEW | 211k | 33.13 |
|
| Definium Therapeutics Com Shs (DFTX) | 0.2 | $6.5M | NEW | 344k | 18.90 |
|
| Cytokinetics (CYTK) | 0.2 | $6.0M | NEW | 92k | 65.91 |
|
| Disc Medicine (IRON) | 0.2 | $5.0M | -29% | 78k | 63.94 |
|
| Veradermics Common Stock | 0.2 | $4.6M | NEW | 73k | 63.15 |
|
| Harmony Biosciences Hldgs In (HRMY) | 0.2 | $4.3M | NEW | 153k | 28.01 |
|
| Vaxcyte (PCVX) | 0.1 | $2.9M | NEW | 51k | 58.11 |
|
| Mirum Pharmaceuticals (MIRM) | 0.1 | $2.5M | +19% | 28k | 92.38 |
|
| Nextcure (NXTC) | 0.1 | $2.4M | 223k | 10.68 |
|
|
| Savara (SVRA) | 0.1 | $2.0M | +19% | 365k | 5.46 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $1.9M | +19% | 34k | 56.78 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $1.7M | +19% | 79k | 22.26 |
|
| Tenax Therapeutics (TENX) | 0.1 | $1.7M | NEW | 104k | 15.99 |
|
| Jade Biosciences (JBIO) | 0.1 | $1.5M | 107k | 14.05 |
|
|
| Wave Life Sciences SHS (WVE) | 0.1 | $1.4M | +19% | 189k | 7.25 |
|
| Septerna (SEPN) | 0.0 | $1.1M | NEW | 48k | 24.03 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $587k | NEW | 142k | 4.14 |
|
| Bolt Biotherapeutics (BOLT) | 0.0 | $556k | 138k | 4.04 |
|
|
| Soleno Therapeutics (SLNO) | 0.0 | $492k | +18% | 15k | 33.48 |
|
| Imagenebio (IMA) | 0.0 | $159k | 32k | 5.00 |
|
|
| Zymeworks Del (ZYME) | 0.0 | $40k | NEW | 1.6k | 25.04 |
|
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2026 Q1 filed May 15, 2026
- Sofinnova Investments 2025 Q4 filed Feb. 13, 2026
- Sofinnova Investments 2025 Q3 filed Nov. 14, 2025
- Sofinnova Investments 2025 Q2 filed Aug. 14, 2025
- Sofinnova Investments 2025 Q1 filed May 15, 2025
- Sofinnova Investments 2024 Q4 filed Feb. 14, 2025
- Sofinnova Investments 2024 Q3 filed Nov. 13, 2024
- Sofinnova Investments 2023 Q4 restated filed Aug. 15, 2024
- Sofinnova Investments 2024 Q1 restated filed Aug. 14, 2024
- Sofinnova Investments 2024 Q2 filed Aug. 9, 2024
- Sofinnova Investments 2024 Q1 filed May 15, 2024
- Sofinnova Investments 2023 Q3 filed Nov. 14, 2023
- Sofinnova Investments 2023 Q2 filed Aug. 14, 2023
- Sofinnova Investments 2023 Q1 filed May 11, 2023
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022